arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Greenland Mines Ltd

GRML
$3.57 ▼ -0.35 (-8.81%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
22 Visible periods
20 Metrics
Peer-ranked Benchmarks
Price Chart
16
Health
Poor
Bearish
auto_awesome

Analytical Summary

Greenland Mines Ltd faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $451.7M
Dividend Yield —
Revenue Growth —
Op. Margin —
ROIC -7.5% ↗
FCF / Share $-0.05 ↘
Trailing P/E —
Price / Book 9.8x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

22-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-13.86M
↓ -520.3% —
FCF / Share Free cash flow per share
$-0.05
↓ -2.1% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓
8
Financial Health ↓
14
Cash Quality
42

Dividend History

Dividend / share · sourced from SEC filings
$16.50 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 5 years · 22 quarters